Literature DB >> 6869121

Effects of leukotrienes C4 and D4 on guinea-pig heart and the participation of SRS-A in the manifestations of guinea-pig cardiac anaphylaxis.

I C Ezeamuzie, E S Assem.   

Abstract

Synthetic leukotrienes C4 and D4 (LTC and LTD) were found to possess potent coronary vasoconstrictor and cardiac depressant actions on isolated guinea-pig hearts. We therefore went further to investigate the possibility that endogenously released slow-reacting substance of anaphylaxis (SRS-A) might be responsible for the coronary vasoconstriction and negative inotropism in guinea-pig cardiac anaphylaxis. Results using time-course analysis as well as the specific SRS antagonist FPL 55712 have shown that SRS-A released during cardiac anaphylaxis was unlikely to be responsible for the early and most dramatic phase of coronary vasoconstriction that usually occurred at the 2nd min after antigen challenge, but could possibly be responsible for the latter and more prolonged phase occurring between the 6th and 14th min. This is because SRS-A release was found to peak at the 4th min after antigen challenge, 2 min after vasoconstriction had already peaked. Moreover, this early component of coronary vasoconstriction could not be blocked by FPL 55712, whereas the latter component was significantly reduced by the antagonist. The negative inotropism following cardiac anaphylaxis was also found to be significantly reduced by FPL 55712, thus suggesting SRS-A involvement. However, our experiments did not show whether the two actions were direct effects of SRS-A or whether contractility failure was a consequence of coronary vasoconstriction.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6869121     DOI: 10.1007/bf01967327

Source DB:  PubMed          Journal:  Agents Actions        ISSN: 0065-4299


  15 in total

1.  The release of histamine and formation of a slow-reacting substance (SRS-A) during anaphylactic shock.

Authors:  W E BROCKLEHURST
Journal:  J Physiol       Date:  1960-06       Impact factor: 5.182

2.  Radioimmunological determination of thromboxane release in cardiac anaphylaxis.

Authors:  H Anhut; W Bernauer; B A Peskar
Journal:  Eur J Pharmacol       Date:  1977-07-01       Impact factor: 4.432

3.  Effects of exogenous and immunologically released histamine on the isolated heart: a quantitative comparison.

Authors:  R Levi
Journal:  J Pharmacol Exp Ther       Date:  1972-08       Impact factor: 4.030

4.  Coronary arterial smooth muscle contraction by a substance released from platelets: evidence that it is thromboxane A2.

Authors:  E F Ellis; O Oelz; L J Roberts; N A Payne; B J Sweetman; A S Nies; J A Oates
Journal:  Science       Date:  1976-09-17       Impact factor: 47.728

5.  Prostaglandin, slow-reacting substance, and histamine release from anaphylactic guinea-pig hearts, and its pharmacological modification.

Authors:  R Liebig; W Bernauer; B A Peskar
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1975       Impact factor: 3.000

6.  The influences of andrenotropic drugs and noradrenaline on the histamine release in cardiac anaphylaxis in vitro.

Authors:  A Giotti; A Guidotti; P F Mannaioni; L Zilletti
Journal:  J Physiol       Date:  1966-06       Impact factor: 5.182

7.  Leukotrienes C4, D4 and E4: effects on human and guinea-pig cardiac preparations in vitro.

Authors:  J A Burke; R Levi; Z G Guo; E J Corey
Journal:  J Pharmacol Exp Ther       Date:  1982-04       Impact factor: 4.030

8.  Slow reacting substances of anaphylaxis: identification of leukotrienes C-1 and D from human and rat sources.

Authors:  R A Lewis; K F Austen; J M Drazen; D A Clark; A Marfat; E J Corey
Journal:  Proc Natl Acad Sci U S A       Date:  1980-06       Impact factor: 11.205

9.  The cardiac effects of prostaglandins and their modification by the prostaglandin antagonist N-0164.

Authors:  G Allan; R Levi
Journal:  J Pharmacol Exp Ther       Date:  1980-07       Impact factor: 4.030

10.  Thromboxane and prostacyclin release during cardiac immediate hypersensitivity reactions in vitro.

Authors:  G Allan; R Levi
Journal:  J Pharmacol Exp Ther       Date:  1981-04       Impact factor: 4.030

View more
  1 in total

1.  Cardiac mast cells: partial purification of guinea-pig atrial mast cells and release from them of histamine and leukotriene C4 by immune and non-immune stimuli.

Authors:  E S Assem; F R Machado; N S Ghanem
Journal:  Agents Actions       Date:  1986-04
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.